PE: How do global pharma growth strategies differ from domestic strategies? Ackerman: There are two different models for ...

Shandong Xinhua Pharmaceutical Company Limited Class H ( ($HK:0719) ) has provided an update. Shandong Xinhua Pharmaceutical Company Limited has ...

Marksans Pharma Ltd (BOM:524404) reports robust revenue growth and strategic advancements despite pricing pressures in the UK market.

Progressing Phase 2 studies for ratutrelvir, a ritonavir-free, protease inhibitor regimen in development for Acute and Long ...

Mysuru hosts a global conference on sustainable brain health, uniting leading experts to discuss advancements in ...

POTOMAC, MARYLAND / ACCESS Newswire / November 10, 2025 / IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE ...

At just 19, Sheetal Arora was thrown in at the deep end of operations at Mankind Pharma. Though a family-run enterprise, he ...

For the third quarter of 2025, Ascendis Pharma reported a net loss of €61.0 million, or €1.00 per share basic and diluted compared to a net loss of €99.2 million, or €1.72 per share basic and diluted ...

The future of engagement isn’t about mapping journeys for HCPs. It’s about earning relevance inside the journeys they’re already living.

NEW DELHI : The Centre has extended the deadline for applying for the ₹ 5,000-crore Promotion of Research and Innovation in ...

When Big Pharma ties its corporate social responsibility initiatives to patients' needs, too often it veers into theater.